BioMarin Pharmaceutical announced it will present at several major healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, Citi, and Morgan Stanley events. The presentations will be available live via audio webcast and archived on BioMarin's website. As a leader in rare disease biotech, BioMarin continues to showcase its innovation and pipeline progress to investors. These events provide an opportunity for investors to hear directly from management about the company's developments and future outlook.
G-III Apparel Group reported Q2 earnings per share of $0.26, surpassing analyst expectations of $0.23, but its revenue of $554.1 million fell short of the $570.4 million forecast. Despite the revenue miss and a decline from last year's $613.3 million...
Yext, Inc. reported Q2 earnings of $0.21 per share, surpassing the expected $0.17, marking a 23% earnings surprise. However, its revenue fell slightly to $111.1 million, missing analyst estimates and declining from the previous year. Following the ea...
Ollie's Bargain Outlet Holdings, Inc. reported Q2 earnings per share of $1.42, beating analyst estimates despite a slight revenue miss due to weather and economic pressures. The company grew net sales by 9.1%, opened 15 new stores, and expanded its l...
Resideo's CEO, Thomas Surran, purchased 15,000 shares of the company at a price of $20.46 per share. This insider buying often indicates confidence in the company's future prospects. Investors may view this move as a positive signal about Resideo's g...
Hewlett Packard Enterprise (HPE) is set to report strong Q3 earnings with EPS projected at $0.93, more than double last year, and revenue expected to reach $11.97 billion. Investors are particularly focused on the profitability of HPE's AI segment, w...
